Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATNM Actinium Pharmaceuticals, Inc.

盘后交易 05-06 16:52:26 EDT

8.84

-0.12

-1.34%

盘后8.84

+0.000.00%

16:20 EDT

最高9.00	最低8.35	成交量28.82万
今开9.00	昨收8.96	日振幅7.25%
总市值2.63亿	流通市值2.56亿	总股本2,978万
成交额249.84万	换手率0.99%	流通股本2,900万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATNM","market":"US","secType":"STK","nameCN":"Actinium Pharmaceuticals, Inc.","latestPrice":8.84,"timestamp":1715025600000,"preClose":8.96,"halted":0,"volume":288175,"hourTrading":{"tag":"盘后","latestPrice":8.84,"preClose":8.84,"latestTime":"16:20 EDT","volume":252,"amount":2227.68,"timestamp":1715026800489},"delay":0,"floatShares":28995708,"shares":29783451,"eps":-1.710807,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.12,"latestTime":"05-06 16:52:26 EDT","open":9,"high":9,"low":8.35,"amount":2498406.35895,"amplitude":0.072545,"askPrice":9.59,"askSize":100,"bidPrice":7.66,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.710807,"exchange":"AMEX","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715040000000},"adr":0,"adjPreClose":8.96,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.81,"preClose":8.96,"latestTime":"09:29 EDT","volume":92,"amount":817.910038,"timestamp":1715002198508},"postHourTrading":{"tag":"盘后","latestPrice":8.84,"preClose":8.84,"latestTime":"16:20 EDT","volume":252,"amount":2227.68,"timestamp":1715026800489},"volumeRatio":0.732777},"requestUrl":"/m/hq/s/ATNM/","defaultTab":"news","newsList":[{"id":"2433471357","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大跌5.13%报8.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433471357","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433471357?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:40","pubTimestamp":1715002849,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时40分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价大幅下挫5.13%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Allarity Therapeutics, Inc.、Tc Biopharm  Plc、Plus Therapeutics, Inc.较为活跃，换手率分别为564.42%、343.37%、40.48%，振幅较大的相关个股有Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.、Akari Therapeutics Plc，振幅分别为38.36%、29.05%、16.90%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506214049861eb2f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506214049861eb2f5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432988180","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432988180","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432988180?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:22","pubTimestamp":1714659723,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时22分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速上涨5.01%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.04%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。消息层面，截至22时22分，《HC Wainwright & Co.：重申Actinium Pharma评级，由买入调整至买入评级, 目标价50.00美元。》资讯为影响Actinium Pharmaceuticals, Inc. 的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022222037925b2aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022222037925b2aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431869298","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨6.26%报7.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431869298","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431869298?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:01","pubTimestamp":1714399280,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时01分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价大幅上涨6.26%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。消息层面，截至22时01分，《HC Wainwright & Co.：重申Actinium Pharma评级，由买入调整至买入评级, 目标价50.00美元。》资讯为影响Actinium Pharmaceuticals, Inc. 的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292201207924f047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292201207924f047&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431339768","title":"HC Wainwright & Co.：重申Actinium Pharma(ATNM.US)评级，由买入调整至买入评级, 目标价50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431339768","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431339768?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:16","pubTimestamp":1714385797,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Actinium Pharma(ATNM.US)评级，由买入调整至买入评级, 目标价50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291816408b618daa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291816408b618daa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430253858","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430253858","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430253858?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:30","pubTimestamp":1714069807,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日02时30分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下挫5.52%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为2440.71%、248.27%、43.36%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zura Bio Limited C/Wts 、Eyenovia, Inc.，振幅分别为118.04%、47.72%、47.06%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260230077a55c68b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260230077a55c68b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429297133","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429297133","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429297133?lang=zh_cn&edition=full","pubTime":"2024-04-23 00:54","pubTimestamp":1713804876,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日00时54分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速拉升5.55%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Moolec Science Sa、Nkgen Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为192.36%、84.83%、59.19%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Effector Therapeutics Inc C/Wts 31/12/2025 ，振幅分别为247.52%、82.14%、55.00%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230054377a549dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230054377a549dd1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428652322","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428652322","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428652322?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:42","pubTimestamp":1713534122,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时42分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速拉升5.10%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.64%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419214202861e774e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419214202861e774e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428378602","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428378602","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428378602?lang=zh_cn&edition=full","pubTime":"2024-04-18 03:04","pubTimestamp":1713380646,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日03时04分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速下挫5.04%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tracon Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Palisade Bio, Inc.、Bio-Path Holdings, Inc.、Longeveron Inc.较为活跃，换手率分别为173.39%、72.35%、62.02%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tracon Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为80.94%、69.01%、51.99%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418030406792147eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418030406792147eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427751618","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘大幅下挫5.09%报8.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427751618","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427751618?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:38","pubTimestamp":1713278319,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时38分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价大幅跳水5.09%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Jaguar Health, Inc.、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为2318.89%、128.52%、122.81%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.、Palisade Bio, Inc.，振幅分别为101.94%、97.81%、75.72%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622383987e80ff2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622383987e80ff2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427054887","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘急速下挫5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427054887","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427054887?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:47","pubTimestamp":1713206872,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时47分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速下挫5.22%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.40%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160247537a52e129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160247537a52e129&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426738431","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.39%报8.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426738431","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426738431?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:52","pubTimestamp":1712929944,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时52分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速跳水5.39%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为2302.83%、810.77%、36.97%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、Qualigen Therapeutics, Inc.，振幅分别为69.81%、60.95%、17.87%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221522479203ae7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221522479203ae7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424392732","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨5.20%报9.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424392732","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424392732?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:40","pubTimestamp":1712238035,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时40分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速拉升5.20%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.39%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404214036861e3674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404214036861e3674&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424956849","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424956849","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424956849?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:56","pubTimestamp":1712152577,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时56分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速上涨5.23%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，方舟生物医药、Kintara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为341.35%、193.53%、20.71%，振幅较大的相关个股有方舟生物医药、Kintara Therapeutics, Inc.、Tracon Pharmaceuticals, Inc.，振幅分别为50.29%、49.10%、25.02%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403215617861e352a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403215617861e352a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420751722","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420751722","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420751722?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:31","pubTimestamp":1710948679,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日23时31分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价大幅拉升5.12%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.84%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032023311987e7a6d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032023311987e7a6d7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420463222","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大涨16.21%报7.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420463222","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420463222?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:31","pubTimestamp":1710855080,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时31分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速上涨16.21%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为426.31%、141.27%、117.31%，振幅较大的相关个股有Enveric Biosciences, Inc.、Salarius Pharmaceuticals, Inc.、Lantern Pharma Inc.，振幅分别为17.27%、11.59%、11.23%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921312087986d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921312087986d35&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420140866","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘大幅下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420140866","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420140866?lang=zh_cn&edition=full","pubTime":"2024-03-18 22:23","pubTimestamp":1710771822,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日22时23分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速下跌5.33%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.31%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318222343861df203&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318222343861df203&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419078339","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速上涨5.26%报6.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419078339","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419078339?lang=zh_cn&edition=full","pubTime":"2024-03-16 00:48","pubTimestamp":1710521335,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日00时48分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速拉升5.26%。其相关个股中，杰龙、Better Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为325.78%、79.25%、27.93%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物，振幅分别为114.29%、63.00%、49.00%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316004855861deb95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316004855861deb95&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419332119","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 下午盘快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419332119","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419332119?lang=zh_cn&edition=full","pubTime":"2024-03-15 01:29","pubTimestamp":1710437347,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日01时29分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速下跌5.02%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为781.07%、178.10%、153.16%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、知临集团，振幅分别为110.40%、80.77%、76.91%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150129077a4cbf23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150129077a4cbf23&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.actiniumpharma.com","stockEarnings":[{"period":"1week","weight":0.3042},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.6906},{"period":"6month","weight":0.8824},{"period":"1year","weight":0.0101},{"period":"ytd","weight":0.7638}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Actinium Pharmaceuticals, Inc.于1997年10月6日在内华达州注册成立。该公司曾是一家空壳公司，在市场上与合适的经营公司合并。该公司现在是一家生物制药公司，专注于抗癌药物的540亿美元的市场。该公司最先进的产品是Actimab -A ，含有AC-225抗体药物结构，目前在急性髓系白血病（AML）和Iomab-B——一种包含iodine131的抗体药物结构进行人体临床试验，用于造血干细胞移植时使用。该公司目前正在设计并申请一项造血干细胞移植的试验，主要针对老年患者难治的复发性急性髓系白血病。该公司正在利用其在放射免疫治疗领域的专业知识开发治疗癌症的药物。此外， AC-225为基础的药物开发依赖于专利的α粒子免疫治疗技术（ APIT ）平台，这是与Memorial Sloan Kettering癌症中心合作开发的技术，该中心的间接附属公司Actinium Holdings有限责任公司是制药公司的大股东。APIT技术与单克隆抗体结合时非常有效，但相对安全的α粒子会发射放射性同位素，尤其是锕225和铋213 ，最终药物结构的设计是专门针对并且杀死癌细胞，同时尽量减少副作用。该公司拟开发不同类型的癌症治疗产品，从与大型制药公司的合作和直接在专业市场销售其产品获得收益。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.050048},{"month":2,"riseRate":0.4,"avgChangeRate":-0.009843},{"month":3,"riseRate":0.1,"avgChangeRate":-0.087476},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.045042},{"month":5,"riseRate":0.727273,"avgChangeRate":0.093872},{"month":6,"riseRate":0.2,"avgChangeRate":-0.015645},{"month":7,"riseRate":0.4,"avgChangeRate":-0.0283},{"month":8,"riseRate":0.2,"avgChangeRate":-0.053484},{"month":9,"riseRate":0.5,"avgChangeRate":0.042952},{"month":10,"riseRate":0.6,"avgChangeRate":0.072278},{"month":11,"riseRate":0.4,"avgChangeRate":-0.037769},{"month":12,"riseRate":0.3,"avgChangeRate":-0.055118}],"exchange":"AMEX","name":"Actinium Pharmaceuticals, Inc.","nameEN":"Actinium Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Actinium Pharmaceuticals, Inc.,ATNM,Actinium Pharmaceuticals, Inc.股票,Actinium Pharmaceuticals, Inc.股票老虎,Actinium Pharmaceuticals, Inc.股票老虎国际,Actinium Pharmaceuticals, Inc.行情,Actinium Pharmaceuticals, Inc.股票行情,Actinium Pharmaceuticals, Inc.股价,Actinium Pharmaceuticals, Inc.股市,Actinium Pharmaceuticals, Inc.股票价格,Actinium Pharmaceuticals, Inc.股票交易,Actinium Pharmaceuticals, Inc.股票购买,Actinium Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况